Skip to main content

N8 LOGO Pill - orange six-sided, 11mm

Generic Name: buprenorphine/naloxone

Pill with imprint N8 LOGO is Orange, Six-sided and has been identified as Suboxone buprenorphine hydrochloride 8 mg (base) / naloxone hydrochloride 2 mg (base). It is supplied by Reckitt Benckiser Pharmaceuticals, Inc.

Suboxone is used in the treatment of Opioid Use Disorder and belongs to the drug class narcotic analgesic combinations. Risk cannot be ruled out during pregnancy. Suboxone buprenorphine hydrochloride 8 mg (base) / naloxone hydrochloride 2 mg (base) is classified as a Schedule 3 controlled substance under the Controlled Substance Act (CSA).

Images for N8 LOGO

Suboxone buprenorphine hydrochloride 8 mg (base) / naloxone hydrochloride 2 mg (base) N8 LOGO Front
Suboxone buprenorphine hydrochloride 8 mg (base) / naloxone hydrochloride 2 mg (base) N8 LOGO Back
Suboxone buprenorphine hydrochloride 8 mg (base) / naloxone hydrochloride 2 mg (base) N8 LOGO

Suboxone

Generic Name
buprenorphine/naloxone
Imprint
N8 LOGO
Strength
buprenorphine hydrochloride 8 mg (base) / naloxone hydrochloride 2 mg (base)
Color
Orange
Size
11.00 mm
Shape
Six-sided
Availability
Prescription only
Drug Class
Narcotic analgesic combinations
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
3 - Moderate abuse potential
Labeler / Supplier
Reckitt Benckiser Pharmaceuticals, Inc.
National Drug Code (NDC)
12496-1306 (Discontinued)
Inactive Ingredients
lactose anhydrous, mannitol, corn starch, povidone k30, citric acid monohydrate, sodium citrate, FD&C Yellow No. 6, magnesium stearate, acesulfame potassium

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related images for "N8 LOGO"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.